Analyzing pharmacogenetics cost effectiveness and savings across common health conditions in the United States
{{output}}
This review describes healthcare cost effectiveness/savings for pharmacogenetics (PGx) and relevant clinical outcomes in selected common health conditions. PGx allows targeted drug treatment based on genotype and phenotype. Studies highlight how PGx testing re... ...
